InvestSMART

Alterity Therapeutics Limited (ASX: ATH) - Announcements

Current share price for ATH : $0.265 0.02 (7.02%)+

ASX company news and announcements for Alterity Therapeutics Limited (ATH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alterity Therapeutics Limited (ATH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alterity Therapeutics Limited (ATH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alterity Therapeutics Limited (ATH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$61 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2026 11:39AM $0.260 $0.265 risen by 1.92%
$61 Proposed issue of securities - ATH 23 Oct 2026 4:20PM $0.255 $0.265 risen by 3.92%
$61 Notification regarding unquoted securities - ATH 23 Oct 2026 10:29AM $0.265 $0.265 fallen by 0%
$61 Notification regarding unquoted securities - ATH 23 Oct 2026 10:28AM $0.265 $0.265 fallen by 0%
$61 Notice of Annual General Meeting/Proxy Form 21 Oct 2026 4:05PM $0.255 $0.265 risen by 3.92%
$61 Changes to Managing Director Terms of Employment 21 Oct 2026 4:00PM $0.255 $0.265 risen by 3.92%
$61 Alterity to Present at the Craig-Hallum Biotech Conference 19 Oct 2026 8:08AM $0.310 $0.265 fallen by 14.52%
$61 Alterity to Present at Canaccord Drug and Device Conference 9 Oct 2026 2:52PM $0.365 $0.265 fallen by 27.40%
$61 Alterity Presents New Analyses of ATH434 Phase 2 Data in MSA 5 Oct 2026 10:03AM $0.380 $0.265 fallen by 30.26%
$61 Date of AGM and Closing Date for Director Nominations 25 Sep 2026 1:46PM $0.425 $0.265 fallen by 37.65%
$61 Corporate Presentation September 2026 23 Sep 2026 9:26AM $0.420 $0.265 fallen by 36.90%
$61 Alterity Therapeutics to Present at ASX SMIDcaps Conference 18 Sep 2026 9:36AM $0.420 $0.265 fallen by 36.90%
$61 Application for quotation of securities - ATH 16 Sep 2026 12:36PM $0.430 $0.265 fallen by 38.37%
$61 Cleansing Notice Under Section 708A 8 Sep 2026 11:59AM $0.485 $0.265 fallen by 45.36%
$61 Application for quotation of securities - ATH 8 Sep 2026 11:41AM $0.495 $0.265 fallen by 46.46%
$61 Alterity to Present at Cantor Global Healthcare Conference 3 Sep 2026 9:26AM $0.520 $0.265 fallen by 49.04%
$61 Change of Director's Interest Notice - Stamler 2 Sep 2026 12:03PM $0.505 $0.265 fallen by 47.52%
$61 Change of Director's Interest Notice - Marks 2 Sep 2026 12:02PM $0.505 $0.265 fallen by 47.52%
$61 Application for quotation of securities - ATH 1 Sep 2026 2:54PM $0.500 $0.265 fallen by 47%
$61 Alterity Therapeutics Filed Form 20-F and XBRL Data with SEC 31 Aug 2026 12:50PM $0.505 $0.265 fallen by 47.52%
$61 $4.2M Options Underwriting Agreement Executed 31 Aug 2026 9:51AM $0.520 $0.265 fallen by 49.04%
$61 Application for quotation of securities - ATH 28 Aug 2026 6:54PM $0.520 $0.265 fallen by 49.04%
$61 Corporate Governance Statement 28 Aug 2026 3:34PM $0.510 $0.265 fallen by 48.04%
$61 Appendix 4G 28 Aug 2026 3:33PM $0.510 $0.265 fallen by 48.04%
$61 Appendix 4E and 2026 Annual Report 28 Aug 2026 3:33PM $0.510 $0.265 fallen by 48.04%

1 - 25 of 584 results

Page 1 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.